143 related articles for article (PubMed ID: 11378378)
21. Solid-phase synthesis of an arylsulfone hydroxamate library.
Salvino JM; Mathew R; Kiesow T; Narensingh R; Mason HJ; Dodd A; Groneberg R; Burns CJ; McGeehan G; Kline J; Orton E; Tang SY; Morrisette M; Labaudininiere R
Bioorg Med Chem Lett; 2000 Aug; 10(15):1637-40. PubMed ID: 10937713
[TBL] [Abstract][Full Text] [Related]
22. A quantitative structure-activity relationship study on some novel series of hydroxamic acid analogs acting as matrix metalloproteinase inhibitors.
Kumaran S; Gupta SP
Med Chem; 2007 Mar; 3(2):167-73. PubMed ID: 17348854
[TBL] [Abstract][Full Text] [Related]
23. A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.
Vinh A; Gaspari TA; Liu HB; Dousha LF; Widdop RE; Dear AE
J Vasc Res; 2008; 45(2):143-52. PubMed ID: 17957103
[TBL] [Abstract][Full Text] [Related]
24. Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.
Huang A; Joseph-McCarthy D; Lovering F; Sun L; Wang W; Xu W; Zhu Y; Cui J; Zhang Y; Levin JI
Bioorg Med Chem; 2007 Sep; 15(18):6170-81. PubMed ID: 17606376
[TBL] [Abstract][Full Text] [Related]
25. The discovery of anthranilic acid-based MMP inhibitors. Part 3: incorporation of basic amines.
Levin JI; Chen JM; Du MT; Nelson FC; Wehr T; DiJoseph JF; Killar LM; Skala S; Sung A; Sharr MA; Roth CE; Jin G; Cowling R; Di L; Sherman M; Xu ZB; March CJ; Mohler KM; Black RA; Skotnicki JS
Bioorg Med Chem Lett; 2001 Nov; 11(22):2975-8. PubMed ID: 11677139
[TBL] [Abstract][Full Text] [Related]
26. Orally active, antimetastatic, nontoxic diphenyl ether-derived carbamoylphosphonate matrix metalloproteinase inhibitors.
Frant J; Veerendhar A; Chernilovsky T; Nedvetzki S; Vaksman O; Hoffman A; Breuer E; Reich R
ChemMedChem; 2011 Aug; 6(8):1471-7. PubMed ID: 21656908
[TBL] [Abstract][Full Text] [Related]
27. Selective non-zinc binding MMP-2 inhibitors: Novel benzamide Ilomastat analogs with anti-tumor metastasis.
Song J; Peng P; Chang J; Liu MM; Yu JM; Zhou L; Sun X
Bioorg Med Chem Lett; 2016 May; 26(9):2174-8. PubMed ID: 27038494
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and preliminary biological evaluation of new hydroxamate histone deacetylase inhibitors as potential antileukemic agents.
Guandalini L; Cellai C; Laurenzana A; Scapecchi S; Paoletti F; Romanelli MN
Bioorg Med Chem Lett; 2008 Sep; 18(18):5071-4. PubMed ID: 18723349
[TBL] [Abstract][Full Text] [Related]
29. The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.
Martin FM; Beckett RP; Bellamy CL; Courtney PF; Davies SJ; Drummond AH; Dodd R; Pratt LM; Patel SR; Ricketts ML; Todd RS; Tuffnell AR; Ward JW; Whittaker M
Bioorg Med Chem Lett; 1999 Oct; 9(19):2887-92. PubMed ID: 10522712
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.
Cherney RJ; Duan JJ; Voss ME; Chen L; Wang L; Meyer DT; Wasserman ZR; Hardman KD; Liu RQ; Covington MB; Qian M; Mandlekar S; Christ DD; Trzaskos JM; Newton RC; Magolda RL; Wexler RR; Decicco CP
J Med Chem; 2003 May; 46(10):1811-23. PubMed ID: 12723945
[TBL] [Abstract][Full Text] [Related]
31. Identification and optimisation of a series of substituted 5-(1H-pyrazol-3-yl)-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitors.
Price S; Bordogna W; Bull RJ; Clark DE; Crackett PH; Dyke HJ; Gill M; Harris NV; Gorski J; Lloyd J; Lockey PM; Mullett J; Roach AG; Roussel F; White AB
Bioorg Med Chem Lett; 2007 Jan; 17(2):370-5. PubMed ID: 17095213
[TBL] [Abstract][Full Text] [Related]
32. Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770.
Curtin ML; Florjancic AS; Heyman HR; Michaelides MR; Garland RB; Holms JH; Steinman DH; Dellaria JF; Gong J; Wada CK; Guo Y; Elmore IB; Tapang P; Albert DH; Magoc TJ; Marcotte PA; Bouska JJ; Goodfellow CL; Bauch JL; Marsh KC; Morgan DW; Davidsen SK
Bioorg Med Chem Lett; 2001 Jun; 11(12):1557-60. PubMed ID: 11412980
[TBL] [Abstract][Full Text] [Related]
33. Cyclic phosphinamides and phosphonamides, novel series of potent matrix metalloproteinase inhibitors with antitumour activity.
Sørensen MD; Blaehr LK; Christensen MK; Høyer T; Latini S; Hjarnaa PJ; Björkling F
Bioorg Med Chem; 2003 Dec; 11(24):5461-84. PubMed ID: 14642591
[TBL] [Abstract][Full Text] [Related]
34. A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.
Rossello A; Nuti E; Catalani MP; Carelli P; Orlandini E; Rapposelli S; Tuccinardi T; Atkinson SJ; Murphy G; Balsamo A
Bioorg Med Chem Lett; 2005 May; 15(9):2311-4. PubMed ID: 15837315
[TBL] [Abstract][Full Text] [Related]
35. Novel isatin-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
Nam NH; Huong TL; Dung do TM; Dung PT; Oanh DT; Quyen D; Thao le T; Park SH; Kim KR; Han BW; Yun J; Kang JS; Kim Y; Han SB
Eur J Med Chem; 2013; 70():477-86. PubMed ID: 24185378
[TBL] [Abstract][Full Text] [Related]
36. Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.
Levin JI; Gu Y; Nelson FC; Zask A; DiJoseph JF; Sharr MA; Sung A; Jin G; Cowling R; Chanda P; Cosmi S; Hsiao CL; Edris W; Wilhelm J; Killar LM; Skotnicki JS
Bioorg Med Chem Lett; 2001 Jan; 11(2):239-42. PubMed ID: 11206468
[TBL] [Abstract][Full Text] [Related]
37. Development of matrix metalloproteinase inhibitors in cancer therapy.
Hidalgo M; Eckhardt SG
J Natl Cancer Inst; 2001 Feb; 93(3):178-93. PubMed ID: 11158186
[TBL] [Abstract][Full Text] [Related]
38. Ongoing trials with matrix metalloproteinase inhibitors.
Brown PD
Expert Opin Investig Drugs; 2000 Sep; 9(9):2167-77. PubMed ID: 11060801
[TBL] [Abstract][Full Text] [Related]
39. Marimastat: the clinical development of a matrix metalloproteinase inhibitor.
Steward WP; Thomas AL
Expert Opin Investig Drugs; 2000 Dec; 9(12):2913-22. PubMed ID: 11093361
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.
Remiszewski SW; Sambucetti LC; Atadja P; Bair KW; Cornell WD; Green MA; Howell KL; Jung M; Kwon P; Trogani N; Walker H
J Med Chem; 2002 Feb; 45(4):753-7. PubMed ID: 11831887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
